3 completed. 2 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 2 |
| Phase 2 | 2 | Completed 2 |
Follow Antibe Therapeutics Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy and Safety of ATB-346 Versus Placebo in Osteoarthritis Patients ATB-346 low dose, Placebo, ATB-346 mid-dose - Osteoarthritis | Phase 2 | Completed | Antibe Therapeutics Inc. | 381 | 2019-03-29 | 2022-07-21 |
| To Compare the Gastrointestinal Safety of a 14-Day Oral Dosing Regimen of ATB-346 to Sodium Naproxen in Healthy Subjects ATB-346 OR Placebo, Naproxen sodium - Gastric Ulcer | Phase 1 / Phase 2 | Completed | Antibe Therapeutics Inc. | 258 | 2017-09-08 | 2018-06-06 |
| Study To Assess Safety, Tolerability And PK Of ATB-346 In Healthy Subjects ATB-346, Placebo - Chronic Pain | Phase 1 | Completed | Antibe Therapeutics Inc. | 84 | 2014-06-01 | 2017-07-18 |
Chronic Pain (1) · Osteoarthritis (1) · Pain (1) · Stomach Ulcer (1)
2-(6-methoxy-napthalen-2-yl)-propionic acid 4-thiocarbamoyl-phenyl ester (3) · Naproxen (1)
Canada (3)
Deepen Patel, MD (2)